|
1
|
Courville EL, Wu Y, Kourda J, Roth CG,
Brockmann J, Muzikansky A, Fathi AT, de Leval L, Orazi A and
Hasserjian RP: Clinicopathologic analysis of acute myeloid leukemia
arising from chronic myelomonocytic leukemia. Mod Pathol.
26:751–761. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Appelbaum FR, Gundacker H, Head DR, Slovak
ML, Willman CL, Godwin JE, Anderson JE and Petersdorf SH: Age and
acute myeloid leukemia. Blood. 107:3481–3485. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Döhner H, Weisdorf DJ and Bloomfield CD:
Acute myeloid leukemia. N Engl J Med. 373:1136–1152. 2015.
View Article : Google Scholar
|
|
5
|
Christen F, Hoyer K, Yoshida K, Hou HA,
Waldhueter N, Heuser M, Hills RK, Chan W, Hablesreiter R, Blau O,
et al: Genomic landscape and clonal evolution of acute myeloid
leukemia with t(8;21): An international study on 331 patients.
Blood. 133:1140–1151. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gregory TK, Wald D, Chen Y, Vermaat JM,
Xiong Y and Tse W: Molecular prognostic markers for adult acute
myeloid leukemia with normal cytogenetics. J Hematol Oncol.
2:232009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kurosawa S, Miyawaki S, Yamaguchi T,
Kanamori H, Sakura T, Moriuchi Y, Sano F, Kobayashi T, Yasumoto A,
Hatanaka K, et al: Prognosis of patients with core binding factor
acute myeloid leukemia after first relapse. Haematologica.
98:1525–1531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Froberg JE and Lee JT: Long
noncoding RNAs: Fresh perspectives into the RNA world. Trends
Biochem Sci. 39:35–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Böhmdorfer G and Wierzbicki AT: Control of
chromatin structure by long noncoding RNA. Trends Cell Biol.
25:623–632. 2015. View Article : Google Scholar
|
|
10
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu R, Yao J and Ren Y: A novel circRNA,
circNUP98, a potential biomarker, acted as an oncogene via the
miR-567/PRDX3 axis in renal cell carcinoma. J Cell Mol Med.
24:10177–10188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xing CY, Hu XQ, Xie FY, Yu ZJ, Li HY,
Bin-Zhou, Wu JB, Tang LY and Gao SM: Long non-coding RNA HOTAIR
modulates c-KIT expression through sponging miR-193a in acute
myeloid leukemia. FEBS Lett. 589:1981–1987. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang Y, Wu Y, Chen X, Zhang S, Wang K,
Guan X, Yang K, Li J and Bai Y: A novel long noncoding RNA
linc00460 up-regulated by CBP/P300 promotes carcinogenesis in
esophageal squamous cell carcinoma. Biosci Rep. 37:BSR201710192017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yue QY and Zhang Y: Effects of Linc00460
on cell migration and invasion through regulating
epithelial-mesenchymal transition (EMT) in non-small cell lung
cancer. Eur Rev Med Pharmacol Sci. 22:1003–1010. 2018.PubMed/NCBI
|
|
15
|
Lian Y, Yan C, Xu H, Yang J, Yu Y, Zhou J,
Shi Y, Ren J, Ji G and Wang K: A novel lncRNA, LINC00460, affects
cell proliferation and apoptosis by regulating KLF2 and CUL4A
expression in colorectal cancer. Mol Ther Nucleic Acids.
12:684–697. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang F, Liang S, Liu X, Han L, Wang J and
Du Q: LINC00460 modulates KDM2A to promote cell proliferation and
migration by targeting miR-342-3p in gastric cancer. Onco Targets
Ther. 11:6383–6394. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu X, Wen J, Wang H and Wang Y: Long
non-coding RNA LINC00460 promotes epithelial ovarian cancer
progression by regulating microRNA-338-3p. Biomed Pharmacother.
108:1022–1028. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lian H, Xie P, Yin N, Zhang J, Zhang X, Li
J and Zhang C: Linc00460 promotes osteosarcoma progression via
miR-1224-5p/FADS1 axis. Life Sci. 233:1167572019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sayed D and Abdellatif M: MicroRNAs in
development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao Q, Wang B, Li X and Jiang G: miRNAs
in acute myeloid leukemia. Oncotarget. 8:3666–3682. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv QL, Du H, Liu YL, Huang YT, Wang GH,
Zhang X, Chen SH and Zhou HH: Low expression of microRNA-320b
correlates with tumorigenesis and unfavorable prognosis in glioma.
Oncol Rep. 38:959–966. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H, Cao F, Li X, Miao H, e J, Xing J
and Fu CG: miR-320b suppresses cell proliferation by targeting
c-Myc in human colorectal cancer cells. BMC Cancer. 15:7482015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang S, Zhang X, Sun Q, Zhuang C, Li G,
Sun L and Wang H: LncRNA NR2F2-AS1 promotes tumourigenesis through
modulating BMI1 expression by targeting miR-320b in non-small cell
lung cancer. J Cell Mol Med. 23:2001–2011. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lieb V, Weigelt K, Scheinost L, Fischer K,
Greither T, Marcou M, Theil G, Klocker H, Holzhausen HJ, Lai X, et
al: Serum levels of miR-320 family members are associated with
clinical parameters and diagnosis in prostate cancer patients.
Oncotarget. 9:10402–10416. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z, Zhang Z, Li Y, Arnovitz S, Chen P,
Huang H, Jiang X, Hong GM, Kunjamma RB, Ren H, et al: PBX3 is an
important cofactor of HOXA9 in leukemogenesis. Blood.
121:1422–1431. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun
AG, Zuo Z, Gurbuxani S, Arnovitz S, Weng H, et al: PBX3 and MEIS1
cooperate in hematopoietic cells to drive acute myeloid leukemias
characterized by a core transcriptome of the MLL-rearranged
disease. Cancer Res. 76:619–629. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dickson GJ, Liberante FG, Kettyle LM,
O'Hagan KA, Finnegan DP, Bullinger L, Geerts D, McMullin MF, Lappin
TR, Mills KI, et al: HOXA/PBX3 knockdown impairs growth and
sensitizes cytogenetically normal acute myeloid leukemia cells to
chemotherapy. Haematologica. 98:1216–1225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Müller-Berndorff H, Haas PS, Kunzmann R,
Schulte-Mönting J and Lübbert M: Comparison of five prognostic
scoring systems, the French-American-British (FAB) and World Health
Organization (WHO) classifications in patients with myelodysplastic
syndromes: Results of a single-center analysis. Ann Hematol.
85:502–513. 2006. View Article : Google Scholar
|
|
29
|
Yu R, Yu BX, Chen JF, Lv XY, Yan ZJ, Cheng
Y and Ma Q: Anti-tumor effects of Atractylenolide I on bladder
cancer cells. J Exp Clin Cancer Res. 35:402016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang ML and Bailey NG: Acute myeloid
leukemia genetics: Risk stratification and implications for
therapy. Arch Pathol Lab Med. 139:1215–1223. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carneiro BA, Altman JK, Kaplan JB,
Ossenkoppele G, Swords R, Platanias LC and Giles FJ: Targeted
therapy of acute myeloid leukemia. Expert Rev Anticancer Ther.
15:399–413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Estey EH: Acute myeloid leukemia: 2013
update on risk-stratification and management. Am J Hematol.
88:318–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Li Y, Song HQ and Sun GW: Long
non-coding RNA LINC00899 as a novel serum biomarker for diagnosis
and prognosis prediction of acute myeloid leukemia. Eur Rev Med
Pharmacol Sci. 22:7364–7370. 2018.PubMed/NCBI
|
|
35
|
Ma L, Kuai WX, Sun XZ, Lu XC and Yuan YF:
Long noncoding RNA LINC00265 predicts the prognosis of acute
myeloid leukemia patients and functions as a promoter by activating
PI3K-AKT pathway. Eur Rev Med Pharmacol Sci. 22:7867–7876.
2018.PubMed/NCBI
|
|
36
|
Feng L, Rao M, Zhou Y, Zhang Y and Zhu Y:
Long noncoding RNA 00460 (LINC00460) promotes glioma progression by
negatively regulating miR-320a. J Cell Biochem. 120:9556–9563.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xie X, Xiong G, Wang Q, Ge Y and Cui X:
Long non-coding RNA LINC00460 promotes head and neck squamous cell
carcinoma cell progression by sponging miR-612 to up-regulate AKT2.
Am J Transl Res. 11:6326–6340. 2019.PubMed/NCBI
|
|
38
|
Zhu Y, Yang L, Chong QY, Yan H, Zhang W,
Qian W, Tan S, Wu Z, Lobie PE and Zhu T: Long noncoding RNA
Linc00460 promotes breast cancer progression by regulating the
miR-489-5p/FGF7/AKT axis. Cancer Manag Res. 11:5983–6001. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang J, Lian Y, Yang R, Lian Y, Wu J, Liu
J, Wang K and Xu H: Upregulation of lncRNA LINC00460 facilitates GC
progression through epigenetically silencing CCNG2 by EZH2/LSD1 and
indicates poor outcomes. Mol Ther Nucleic Acids. 19:1164–1175.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pardini B, Sabo AA, Birolo G and Calin GA:
Noncoding RNAs in extracellular fluids as cancer biomarkers: The
new frontier of liquid biopsies. Cancers (Basel). 11:11702019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chiabotto G, Gai C, Deregibus MC and
Camussi G: Salivary extracellular vesicle-associated exRNA as
cancer biomarker. Cancers (Basel). 11:8912019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li K, Sun D, Gou Q, Ke X, Gong Y, Zuo Y,
Zhou JK, Guo C, Xia Z, Liu L, et al: Long non-coding RNA linc00460
promotes epithelial-mesenchymal transition and cell migration in
lung cancer cells. Cancer Lett. 420:80–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang X, Mo FM, Bo H, Xiao L, Chen GY, Zeng
PW, Huang YN, Lei Z, Yuan WJ and Chen ZH: Upregulated expression of
long non-coding RNA, LINC00460, suppresses proliferation of
colorectal cancer. J Cancer. 9:2834–2843. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu X, Dinglin X, Wang X, Luo W, Shen Q, Li
Y, Gu L, Zhou Q, Zhu H, Li Y, et al: Long noncoding RNA XIST
promotes malignancies of esophageal squamous cell carcinoma via
regulation of miR-101/EZH2. Oncotarget. 8:76015–76028. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang W, Zhao C, Zhao J, Zhu Y, Weng X,
Chen Q, Sun H, Mi JQ, Li J, Zhu J, et al: Inactivation of PBX3 and
HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated
leukemic cell survival. Theranostics. 8:4359–4371. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Morgan R and Pandha HS: PBX3 in cancer.
Cancers (Basel). 12:4312020. View Article : Google Scholar : PubMed/NCBI
|
